The GluN2D subunit has been implicated as a potential target in preventing NMDAR-mediated excitotoxicity, particularly that which may contribute to ongoing degeneration in Parkinson’s Disease (Kotermanski and Johnson, 2009). This evidence concerns the gene GRIN2D and Parkinson disease.